AMRC vs BIIB · P/E 17, rev $916.9M vs P/E 21, rev $9.89B
Ameresco Inc (AMRC) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
Ameresco Inc (AMRC) is a engineering & construction company listed on US.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported AMRC revenue for 2026-06-30 was $916.9M. Net income was -$8.6M. AMRC currently screens at market cap $934.2M and trailing P/E 17.2.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
AMRC currently screens at market cap $934.2M and trailing P/E 17.2. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the AMRC and BIIB stock pages for the full models.
Not investment advice.